High-intensity interval training and hyperoxia during chemotherapy: A case report about the feasibility, safety and physical functioning in a colorectal cancer patient

Nils Freitag, Pia Deborah Weber, Tanja Christiane Sanders, Holger Schulz, Wilhelm Bloch, Moritz Schumann, Nils Freitag, Pia Deborah Weber, Tanja Christiane Sanders, Holger Schulz, Wilhelm Bloch, Moritz Schumann

Abstract

Introduction: We conducted a case study to examine the feasibility and safety of high-intensity interval training (HIIT) with increased inspired oxygen content in a colon cancer patient undergoing chemotherapy. A secondary purpose was to investigate the effects of such training regimen on physical functioning.

Case presentation: A female patient (51 years; 49.1 kg; 1.65 m; tumor stage: pT3, pN2a (5/29), pM1a (HEP), L0, V0, R0) performed 8 sessions of HIIT (5 × 3 minutes at 90% of Wmax, separated by 2 minutes at 45% Wmax) with an increased inspired oxygen fraction of 30%. Patient safety, training adherence, cardiorespiratory fitness (peak oxygen uptake and maximal power output during an incremental cycle ergometer test), autonomous nervous function (i.e., heart rate variability during an orthostatic test) as well as questionnaire-assessed quality of life (EORTC QLQ-C30) were evaluated before and after the intervention.No adverse events were reported throughout the training intervention and a 3 months follow-up. While the patient attended all sessions, adherence to total training time was only 51% (102 of 200 minutes; mean training time per session 12:44 min:sec). VO2peak and Wmax increased by 13% (from 23.0 to 26.1 mL min kg) and 21% (from 83 to 100 W), respectively. Heart rate variability represented by the root mean squares of successive differences both in supine and upright positions were increased after the training by 143 and 100%, respectively. The EORTC QLQ-C30 score for physical functioning (7.5%) as well as the global health score (10.7%) improved, while social function decreased (17%).

Conclusions: Our results show that a already short period of HIIT with concomitant hyperoxia was safe and feasible for a patient undergoing chemotherapy for colon cancer. Furthermore, the low overall training adherence of only 51% and an overall low training time per session (∼13 minutes) was sufficient to induce clinically meaningful improvements in physical functioning. However, this case also underlines that intensity and/or length of the HIIT-bouts might need further adjustments to increase training compliance.

Conflict of interest statement

Competing interests: The authors declare that they have no competing interests.

The authors have no conflicts of interest to disclose.

Figures

Figure 1
Figure 1
Timing of basal measurements, exercise interventions and drug administrations; Chemotherapy was administered on 2 consecutive days every week; d days ∗NOTE a second baseline incremental test was performed to clarify cardiovascular uncertainties indicated during the first CPET (the patient completed the same workload during the second baseline assessment). CPET = cardiopulmonary exercise testing.
Figure 2
Figure 2
Self-reported weekly amounts of habitual physical activity, excluding prescribed HIIT sessions.
Figure 3
Figure 3
Heart rate (A) and blood lactate accumulation (B) during the cardiopulmonary exercise test before and after training; + indicates an increase from pre to post at the corresponding workload; - indicates a decrease from pre to post at the corresponding workload. ∗NOTE: the curves for pre are shorter due to a shorter time to exhaustion.
Figure 4
Figure 4
Patient-related outcomes on quality of life assessed by the EORTC QLQ-C30 functional scale (A) and perceived fatigue determined by the FACIT-F subscales (B) before and after the intervention in relation to the maximal values. NOTE: The FACIT-F questionnaire was assessed both before the first and last HIIT session. FACIT-F = functional assessment of chronic illness therapy-fatigue.

References

    1. Labianca R, Nordlinger B, Beretta GD, et al. Early colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24(suppl 6):
    1. Braun MS, Seymour MT. Balancing the efficacy and toxicity of chemotherapy in colorectal cancer. Ther Adv Med Oncol 2011;3:43–52.
    1. Cassidy J, Misset J-L. Oxaliplatin-related side effects: characteristics and management. Semin Oncol 2002;29(5 suppl 15):11–20.
    1. Jim HSL, Small B, Faul LA, et al. depression, sleep, and activity during chemotherapy: daily and intraday variation and relationships among symptom changes. Ann Behav Med 2011;42:321–33.
    1. Brunet J, Burke S, Grocott MPW, et al. The effects of exercise on pain, fatigue, insomnia, and health perceptions in patients with operable advanced stage rectal cancer prior to surgery: a pilot trial. BMC Cancer 2017;17:153.
    1. Kelley GA, Kelley KS. Exercise and cancer-related fatigue in adults: a systematic review of previous systematic reviews with meta-analyses. BMC Cancer 2017;17:693.
    1. Buffart LM, Galvão DA, Brug J, et al. Evidence-based physical activity guidelines for cancer survivors: Current guidelines, knowledge gaps and future research directions. Cancer Treat Rev 2014;40:327–40.
    1. Wisloff U, Stoylen A, Loennechen JP, et al. Superior cardiovascular effect of aerobic interval training versus moderate continuous training in heart failure patients: a randomized study. Circulation 2007;115:3086–94.
    1. Jelleyman C, Yates T, O’Donovan G, et al. The effects of high-intensity interval training on glucose regulation and insulin resistance: a meta-analysis. Obes Rev 2015;16:942–61.
    1. Wens I, Dalgas U, Vandenabeele F, et al. High intensity exercise in multiple sclerosis: effects on muscle contractile characteristics and exercise capacity, a randomised controlled trial. PLoS One 2015;10:e0133697.
    1. Adams SC, DeLorey DS, Davenport MH, et al. Effects of high-intensity aerobic interval training on cardiovascular disease risk in testicular cancer survivors: a phase 2 randomized controlled trial. Cancer 2017;123:4057–65.
    1. Devin JL, Sax AT, Hughes GI, et al. The influence of high-intensity compared with moderate-intensity exercise training on cardiorespiratory fitness and body composition in colorectal cancer survivors: a randomised controlled trial. J Cancer Surviv 2016;10:467–79.
    1. Mallette MM, Stewart DG, Cheung SS. The effects of hyperoxia on sea-level exercise performance, training, and recovery: a meta-analysis. Sport Med 2017;1–23.
    1. Helgerud J, Bjørgen S, Karlsen T, et al. Hyperoxic interval training in chronic obstructive pulmonary disease patients with oxygen desaturation at peak exercise. Scand J Med Sci Sports 2010;20:e170–6.
    1. Brinkmann C, Metten A, Scriba P, et al. Hypoxia and hyperoxia affect serum angiogenic regulators in t2dm men during cycling. Int J Sports Med 2017;38:92–8.
    1. Moore DPP, Weston ARR, Oakley CMM, et al. Effects of increased inspired oxygen concentrations on exercise performance in chronic heart failure. Lancet 1992;339:850–3.
    1. Chronos N, Adams L, Guz A. Effect of hyperoxia and hypoxia on exercise-induced breathlessness in normal subjects. Clin Sci (Lond) 1988;74:531–7. Available at: . Accessed January 30, 2018.
    1. Schumann M, Schulz H, Hackney AC, et al. Feasibility of high-intensity interval training with hyperoxia vs. intermittent hyperoxia and hypoxia in cancer patients undergoing chemotherapy—study protocol of a randomized controlled trial. Contemp Clin Trials Commun 2017;8:213–7.
    1. Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med 1970;2:92–8.
    1. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation, clinical use. Circulation 1996;93:1043–65. . Accessed February 7, 2018.
    1. Oussaidene K, Prieur F, Bougault V, et al. Cerebral oxygenation during hyperoxia-induced increase in exercise tolerance for untrained men. Eur J Appl Physiol 2013;113:2047–56.
    1. Adamsen L, Quist M, Andersen C, et al. Effect of a multimodal high intensity exercise intervention in cancer patients undergoing chemotherapy: randomised controlled trial. BMJ 2009;339:b3410–13410.
    1. Wiskemann J, Schommer K, Jaeger D, et al. Exercise and cancer. Medicine (Baltimore) 2016;95:e4309.
    1. Park SB, Goldstein D, Krishnan AV, et al. Chemotherapy-induced peripheral neurotoxicity: a critical analysis. CA Cancer J Clin 2013;63:419–37.
    1. Mouton C, Ronson A, Razavi D, et al. The relationship between heart rate variability and time-course of carcinoembryonic antigen in colorectal cancer. Auton Neurosci 2012;166:96–9.
    1. Crosswell AD, Lockwood KG, Ganz PA, et al. Low heart rate variability and cancer-related fatigue in breast cancer survivors. Psychoneuroendocrinology 2014;45:58–66.
    1. Billman GE. The LF/HF ratio does not accurately measure cardiac sympatho-vagal balance. Front Physiol 2013;4:26.
    1. Tan X, Wen Q, Wang R, et al. Chemotherapy-induced neutropenia and the prognosis of colorectal cancer: a meta-analysis of cohort studies. Expert Rev Anticancer Ther 2017;17:1077–85.
    1. Mach WJ, Thimmesch AR, Pierce JT, et al. Consequences of hyperoxia and the toxicity of oxygen in the lung. Nurs Res Pract 2011;2011:260482.
    1. He F, Li J, Liu Z, et al. Redox mechanism of reactive oxygen species in exercise. Front Physiol 2016;7:486.

Source: PubMed

3
Sottoscrivi